Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Torii Pharmaceutical Co. Ltd.
Industry Sector: HealthTechnology
CEO: Goichi Matsuda
Number Of Employees: 592
Enterprise Value: $545,511,185
PE Ratio: 22.89
Exchange/Ticker 1: Tokyo:4551
Exchange/Ticker 2: N/A
Latest Market Cap: $792,645,325
BioCentury | Oct 19, 2024
Finance
Biotech restructurings show signs of slowing
Temporary respite or reflection of a stabilizing sector?
BioCentury | Jun 30, 2023
Regulation
Six PDUFA dates on FDA’s July calendar
Decisions due next month include full approval of Leqembi for Alzheimer’s and quizartinib for AML
BioCentury | Jan 22, 2021
Regulation
CAR T Yescarta among new approvals by Japanese regulator
Yescarta became the second approved CAR T therapy in Japan, joining a basket of new approvals by the country’s Ministry of Health, Labour and Welfare. The therapy, developed by Gilead Sciences
BioCentury | Nov 6, 2019
Company News
Nov. 5 Company Quick Takes: Takeda licenses MD Anderson CAR NK cell portfolio; plus Myriad, Canbridge, BioCryst-Torii and Strongbridge
Items per page:
1 - 10 of 74